GO:0042357 thiamine diphosphate metabolic process: Coenzyme Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042357 thiamine diphosphate metabolic process describes the chemical reactions and pathways involving thiamine diphosphate (ThDP, also called thiamine pyrophosphate or TPP), the active coenzyme form of vitamin B1.
• ThDP is an essential cofactor for enzymes of the Krebs cycle, pentose phosphate pathway, and branched-chain amino acid metabolism, including pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase.
• Thiamine status, measured as erythrocyte ThDP or plasma thiamine, is a sensitive biomarker of vitamin B1 sufficiency and responds to fortification.
• Abnormal thiamine metabolism and low ThDP are associated with gestational diabetes, diabetes mellitus, and advanced glycation stress.
• Thiamine supplementation, including benfotiamine and vitamin B1/B2 combinations, can raise erythrocyte ThDP and has been used in mitochondrial encephalomyopathy.
• Studying GO:0042357 requires integrating biochemical assays, genetic models, and CRISPR-based editing of thiamine transporters and ThDP-dependent enzymes.
Description
Thiamine diphosphate (ThDP), also known as thiamine pyrophosphate (TPP), is the biologically active form of vitamin B1 and serves as an essential coenzyme in central carbon metabolism. The Gene Ontology term GO:0042357, thiamine diphosphate metabolic process, encompasses the chemical reactions and pathways that synthesize, utilize, and degrade ThDP within cells. This process is fundamental because ThDP-dependent enzymes catalyze key steps in the Krebs cycle, the pentose phosphate pathway, and amino acid catabolism, linking vitamin B1 availability to cellular energy production and redox balance. Research into GO:0042357 has direct clinical relevance. Thiamine deficiency and altered ThDP homeostasis contribute to diabetic complications, including advanced glycation and gestational diabetes. Erythrocyte ThDP is a reliable biomarker of thiamine status and responds to fortification programs in populations at risk. Moreover, oral benfotiamine can elevate erythrocyte ThDP in dialysis patients, and thiamine-based therapies have been explored in mitochondrial encephalomyopathy. Understanding the molecular mechanisms of ThDP metabolism therefore informs nutrition, metabolic disease, and mitochondrial medicine. At the molecular level, ThDP is synthesized from thiamine by thiamine pyrophosphokinase and is utilized by enzymes such as transketolase, pyruvate dehydrogenase, and alpha-ketoglutarate dehydrogenase. The structural basis of ThDP binding and catalysis has been extensively studied in transketolase, revealing conserved cofactor-binding motifs and catalytic mechanisms. In microorganisms, polyphosphate kinases can phosphorylate thiamine phosphates, highlighting evolutionary diversity in ThDP synthesis. This article synthesizes authoritative GO annotations and verified PubMed literature to provide a research-grade overview of GO:0042357.
thiamine diphosphate metabolic process At A Glance
| GO ID | GO:0042357 |
|---|---|
| GO term | thiamine diphosphate metabolic process |
| Ontology | biological_process |
| Synonym | thiamin diphosphate metabolic process; thiamin diphosphate metabolism; thiamine diphosphate metabolism; thiamine pyrophosphate metabolic process; thiamine pyrophosphate metabolism; thiamin pyrophosphate metabolic process; thiamin pyrophosphate metabolism; TPP metabolic process; TPP metabolism |
| Major function | Synthesis, utilization, and turnover of thiamine diphosphate (ThDP/TPP), the active coenzyme form of vitamin B1, required for Krebs cycle, pentose phosphate pathway, and branched-chain amino acid metabolism. |
| Key enzymes | Thiamine pyrophosphokinase (TPK1), transketolase (TKT), pyruvate dehydrogenase complex (PDH), alpha-ketoglutarate dehydrogenase complex (OGDH), branched-chain alpha-ketoacid dehydrogenase complex (BCKDH). |
| Key transporters | SLC19A2 (THTR1), SLC19A3 (THTR2), SLC25A19 (mitochondrial thiamine pyrophosphate carrier). |
| Biomarker | Erythrocyte thiamine diphosphate (eThDP) and plasma thiamine are established indicators of thiamine status. |
| Clinical relevance | Thiamine deficiency and altered ThDP metabolism are linked to diabetes, gestational diabetes, mitochondrial encephalomyopathy, and advanced glycation. |
What Is GO:0042357?
GO:0042357, thiamine diphosphate metabolic process, is defined as the chemical reactions and pathways involving thiamine diphosphate, a derivative of thiamine (vitamin B1) which acts as a coenzyme in a range of processes including the Krebs cycle. In practical terms, it covers the biosynthesis of ThDP from thiamine, its interconversion with other thiamine phosphates, its binding to and utilization by ThDP-dependent enzymes, and its degradation or recycling.
Why Is thiamine diphosphate metabolic process Important in Cell Biology?
GO:0042357 is important because thiamine diphosphate is the indispensable coenzyme for several rate-limiting enzymes in energy metabolism, and its availability directly affects mitochondrial function, glucose oxidation, and redox homeostasis. Disruption of ThDP metabolism leads to metabolic decompensation, as seen in thiamine deficiency disorders and in diabetes-associated thiamine abnormalities. Because erythrocyte ThDP responds to fortification and supplementation, it serves as a practical biomarker for public health and clinical interventions. Furthermore, genetic defects in thiamine transport or ThDP synthesis can cause severe neurological and mitochondrial disease, making this pathway a target for therapeutic development.
• ThDP is the active coenzyme form of vitamin B1 and is required for the Krebs cycle, pentose phosphate pathway, and branched-chain amino acid catabolism.
• Thiamine diphosphate metabolic process is essential for mitochondrial energy production and cellular redox balance.
• Erythrocyte ThDP is a validated biomarker of thiamine status and responds to fortification in at-risk populations.
• Altered thiamine metabolism is associated with gestational diabetes and advanced glycation stress.
• Diabetes mellitus is linked to lower thiamine status, as shown by systematic review and meta-analysis.
• Benfotiamine administration can raise erythrocyte ThDP concentrations in dialysis patients.
• Thiamine-based therapies have been investigated in mitochondrial encephalomyopathy.
• Transketolase, a ThDP-dependent enzyme, is a model for understanding cofactor binding and catalysis.
• Microbial polyphosphate kinases can phosphorylate thiamine phosphates, revealing alternative routes in ThDP metabolism.
• CRISPR-based models of thiamine transporters and ThDP enzymes can clarify causal roles in metabolic disease.
What Happens During thiamine diphosphate metabolic process?
Thiamine uptake and phosphorylation to ThDP
In simple terms: Cells take up vitamin B1 and add phosphate groups to convert it into the active coenzyme form.
Thiamine is transported into cells by specific carriers such as SLC19A2 and SLC19A3, and in mitochondria by SLC25A19. Inside the cytosol, thiamine pyrophosphokinase (TPK1) catalyzes the transfer of pyrophosphate from ATP to thiamine, yielding thiamine diphosphate (ThDP). This phosphorylation step is the central activation reaction of GO:0042357 and is required for all downstream ThDP-dependent processes. In some microorganisms, polyphosphate kinases can also phosphorylate thiamine phosphates, indicating alternative enzymatic routes for ThDP synthesis.
ThDP as a cofactor for dehydrogenase complexes
In simple terms: ThDP helps enzymes break down sugars and amino acids to release energy.
ThDP binds non-covalently to the E1 subunits of pyruvate dehydrogenase (PDH), alpha-ketoglutarate dehydrogenase (OGDH), and branched-chain alpha-ketoacid dehydrogenase (BCKDH) complexes. In these complexes, ThDP participates in decarboxylation of alpha-keto acids, generating acyl-CoA derivatives and reducing equivalents that feed the Krebs cycle and oxidative phosphorylation. The catalytic mechanism involves formation of a ThDP-ylide intermediate that attacks the substrate carbonyl, a conserved feature across ThDP-dependent enzymes.
ThDP in the pentose phosphate pathway: transketolase
In simple terms: ThDP enables an enzyme called transketolase to rearrange carbon units for nucleotide and NADPH production.
Transketolase (TKT) is a ThDP-dependent enzyme of the pentose phosphate pathway that catalyzes the reversible transfer of two-carbon units between phosphorylated sugars. This reaction links glycolytic intermediates to ribose-5-phosphate synthesis and NADPH production, supporting nucleotide biosynthesis and antioxidant defense. Structural studies of transketolase have defined the ThDP-binding fold and the role of divalent cations in cofactor stabilization, providing a paradigm for understanding ThDP-dependent catalysis.
ThDP turnover and interconversion with other thiamine phosphates
In simple terms: ThDP can be broken down or converted to other thiamine forms, and these interconversions help regulate coenzyme levels.
ThDP exists in equilibrium with thiamine monophosphate and free thiamine through the action of phosphatases and pyrophosphatases. These interconversions allow cells to buffer ThDP concentrations and recycle thiamine when needed. In microorganisms, polyphosphate kinases can phosphorylate thiamine and its phosphates, contributing to ThDP pool dynamics. The balance between synthesis, utilization, and degradation determines the availability of ThDP for coenzyme function.
Compartmentalization of ThDP metabolism
In simple terms: ThDP metabolism happens in different parts of the cell, especially the cytosol and mitochondria.
ThDP synthesis occurs primarily in the cytosol, while ThDP-dependent dehydrogenases reside in the mitochondrial matrix. The mitochondrial carrier SLC25A19 transports ThDP or its precursors into mitochondria, coupling cytosolic synthesis to mitochondrial utilization. Transketolase operates in the cytosol, using the cytosolic ThDP pool for pentose phosphate pathway flux. This compartmentalization ensures that ThDP is available where it is needed and is a key organizational feature of GO:0042357.
Key Genes Involved in GO:0042357 thiamine diphosphate metabolic process
The following genes and proteins are central to thiamine diphosphate metabolic process, encompassing transporters, biosynthetic enzymes, and ThDP-dependent enzymes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TPK1 | Thiamine pyrophosphokinase; converts thiamine to ThDP | Rate-limiting enzyme for ThDP synthesis; target for metabolic studies |
| TKT | Transketolase; ThDP-dependent enzyme of pentose phosphate pathway | Model for ThDP binding and catalysis; links to NADPH and ribose synthesis |
| PDHA1 | E1 alpha subunit of pyruvate dehydrogenase complex; ThDP-dependent | Defects cause pyruvate dehydrogenase deficiency and lactic acidosis |
| PDHB | E1 beta subunit of pyruvate dehydrogenase complex; ThDP-dependent | Required for PDH activity and glucose oxidation |
| OGDH | Alpha-ketoglutarate dehydrogenase; ThDP-dependent | Krebs cycle enzyme; affects mitochondrial energy production |
| DLD | Dihydrolipoamide dehydrogenase; shared subunit of dehydrogenase complexes | Mutations cause E3 deficiency with broad metabolic impact |
| BCKDHA | E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase; ThDP-dependent | Maple syrup urine disease gene; ThDP-dependent catabolism |
| BCKDHB | E1 beta subunit of branched-chain alpha-ketoacid dehydrogenase; ThDP-dependent | Maple syrup urine disease gene; ThDP-dependent catabolism |
| SLC19A2 | Thiamine transporter 1 (THTR1) | Mutations cause thiamine-responsive megaloblastic anemia |
| SLC19A3 | Thiamine transporter 2 (THTR2) | Mutations cause biotin-thiamine-responsive basal ganglia disease |
| SLC25A19 | Mitochondrial thiamine pyrophosphate carrier | Mutations cause Amish microcephaly and ThDP transport defects |
| TPK1 (isoforms) | Thiamine pyrophosphokinase isoforms | Tissue-specific regulation of ThDP synthesis |
| THTPA | Thiamine triphosphatase | Regulates thiamine phosphate derivatives |
| NUDT1 | Nudix hydrolase; may hydrolyze thiamine phosphates | Potential role in ThDP turnover |
| ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase | May influence extracellular thiamine phosphate metabolism |
| PPK (microbial) | Polyphosphate kinase; phosphorylates thiamine phosphates | Microbial model for alternative ThDP synthesis |
How Is thiamine diphosphate metabolic process Regulated?
Thiamine diphosphate metabolic process is regulated at multiple levels. Transcriptional control of thiamine transporters (SLC19A2, SLC19A3) and TPK1 modulates ThDP synthesis in response to cellular demand. Post-translational regulation of ThDP-dependent enzymes, such as phosphorylation of pyruvate dehydrogenase by PDK isoforms, controls flux through dehydrogenase complexes independently of ThDP availability. In microorganisms, polyphosphate kinases can phosphorylate thiamine phosphates, providing an alternative regulatory input to ThDP pools. Additionally, thiamine status itself, reflected by erythrocyte ThDP, responds to dietary intake and fortification, indicating systemic regulation of ThDP metabolism. However, specific master regulators analogous to mTOR or the integrated stress response have not been definitively established for GO:0042357 in the cited literature.
thiamine diphosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC19A2 | Thiamine-responsive megaloblastic anemia | Knockout cell line; thiamine transport assay |
| SLC19A3 | Biotin-thiamine-responsive basal ganglia disease | Knock-in of patient mutations; neuronal differentiation |
| SLC25A19 | Amish microcephaly; mitochondrial ThDP transport defect | Knockout mitochondria; Seahorse respirometry |
| TKT | Pentose phosphate pathway dysfunction; metabolic stress | Point mutation of ThDP-binding residues; metabolic flux analysis |
| PDHA1 | Pyruvate dehydrogenase deficiency; lactic acidosis | Knockout or point mutation; lactate production assay |
Diabetes and gestational diabetes
Abnormal thiamine metabolism and reduced ThDP availability are associated with gestational diabetes, where dysfunctional protection against advanced glycation has been linked to thiamine abnormalities. A systematic review and meta-analysis found an association between diabetes and altered thiamine status, supporting the clinical relevance of ThDP metabolism in diabetes. These findings suggest that maintaining adequate ThDP levels may help mitigate glycation stress in diabetic patients.
Mitochondrial encephalomyopathy
Thiamine and riboflavin supplementation, alone or in combination, has been used in the treatment of mitochondrial encephalomyopathy, with the rationale that ThDP is required for mitochondrial dehydrogenase complexes. Although the evidence is limited, this clinical experience highlights the importance of ThDP metabolism for mitochondrial function.
Thiamine deficiency and neurological disorders
Genetic defects in thiamine transporters (SLC19A2, SLC19A3) and the mitochondrial ThDP carrier (SLC25A19) cause severe neurological and hematological disorders, underscoring the essential role of ThDP metabolism in the nervous system. These conditions often respond to high-dose thiamine supplementation, demonstrating the therapeutic potential of targeting GO:0042357.
From thiamine diphosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TPK1 reduce ThDP levels and affect cell growth? | TPK1 knockout cell line |
| Does a patient mutation in SLC19A3 impair thiamine transport? | SLC19A3 point-mutation knock-in |
| Can tagged TKT reveal ThDP-dependent interactors? | TKT knock-in with affinity tag |
| Does overexpression of SLC19A2 increase ThDP uptake? | SLC19A2 overexpression cell line |
| Does loss of SLC25A19 alter mitochondrial respiration? | SLC25A19 knockout; Seahorse assay |
| Can CRISPR library screening identify modifiers of thiamine dependence? | Genome-wide CRISPR knockout library |
How to Study the thiamine diphosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC for thiamine phosphates | ThDP and other thiamine derivatives | Clinical thiamine status assessment |
| Enzymatic ThDP assay | ThDP-dependent enzyme activity | Functional validation of ThDP metabolism |
| CRISPR knockout | Gene function loss | Testing TPK1, SLC19A2, TKT roles |
| CRISPR point mutation | Specific amino acid changes | Modeling patient variants in SLC19A3 |
| Seahorse respirometry | Mitochondrial respiration | Assessing impact of ThDP metabolism on energy |
| Metabolic flux analysis | Pathway flux | Pentose phosphate pathway activity |
| X-ray crystallography | Protein structure | ThDP binding in transketolase |
| CRISPR library screening | Genome-wide modifiers | Identifying thiamine dependence genes |
Biochemical measurement of ThDP
Erythrocyte thiamine diphosphate (eThDP) and plasma thiamine can be quantified by HPLC or enzymatic assays to assess thiamine status. These methods are used in clinical studies and fortification programs to monitor ThDP levels.
Genetic and CRISPR screens
CRISPR knockout, point-mutation, and knock-in models enable causal testing of genes involved in ThDP metabolism, such as TPK1, SLC19A2, and TKT. Library screening can identify modifiers of thiamine dependence and ThDP-related phenotypes.
Metabolic flux and respirometry
Seahorse respirometry and metabolic flux analysis measure mitochondrial function and pentose phosphate pathway activity in cells with altered ThDP metabolism. These approaches link ThDP availability to energy metabolism.
Structural and biophysical studies
X-ray crystallography and biophysical assays of transketolase and other ThDP-dependent enzymes reveal cofactor-binding mechanisms and catalytic intermediates. Such studies inform the design of inhibitors or activators targeting ThDP metabolism.
How CRISPR Can Be Used to Study GO:0042357 thiamine diphosphate metabolic process
Knockout
CRISPR knockout of TPK1, SLC19A2, SLC19A3, or SLC25A19 can abolish or reduce ThDP synthesis and transport, enabling studies of downstream metabolic consequences. Knockout of TKT or PDHA1 models ThDP-dependent enzyme loss and its impact on pentose phosphate pathway and mitochondrial metabolism.
Point Mutation
Point mutations in SLC19A3 or SLC25A19 can recapitulate patient variants associated with neurological disease, allowing assessment of transport defects and response to thiamine supplementation. Point mutations in TKT can probe ThDP-binding residues and catalytic mechanism.
Knock-in
Knock-in of tagged TKT or TPK1 enables affinity purification and interactome analysis, revealing ThDP-dependent protein complexes. Knock-in of reporter cassettes can monitor ThDP metabolism gene expression in real time.
Overexpression
Overexpression of SLC19A2 or TPK1 can increase ThDP uptake and synthesis, providing gain-of-function models to test whether elevated ThDP protects against metabolic stress. Overexpression of transketolase can enhance pentose phosphate pathway flux.
How EDITGENE Supports thiamine diphosphate metabolic process Research
Researchers studying thiamine diphosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in ThDP synthesis, transport, or utilization. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes within GO:0042357.
Contact EDITGENE today to design your custom CRISPR model for thiamine diphosphate metabolic process research.
Frequently Asked Questions About thiamine diphosphate metabolic process
What is thiamine diphosphate metabolic process?
Thiamine diphosphate metabolic process (GO:0042357) encompasses the chemical reactions and pathways involving thiamine diphosphate (ThDP), the active coenzyme form of vitamin B1, which functions in the Krebs cycle, pentose phosphate pathway, and amino acid metabolism.
What genes are involved in thiamine diphosphate metabolic process?
Key genes include TPK1 (thiamine pyrophosphokinase), TKT (transketolase), PDHA1/PDHB (pyruvate dehydrogenase), OGDH (alpha-ketoglutarate dehydrogenase), BCKDHA/BCKDHB (branched-chain ketoacid dehydrogenase), and transporters SLC19A2, SLC19A3, and SLC25A19.
Why is thiamine diphosphate important for metabolism?
ThDP is an essential cofactor for enzymes that decarboxylate alpha-keto acids in the Krebs cycle and for transketolase in the pentose phosphate pathway, linking vitamin B1 to energy production and redox balance.
How is thiamine diphosphate measured in clinical samples?
Erythrocyte thiamine diphosphate (eThDP) and plasma thiamine are measured by HPLC or enzymatic assays and serve as biomarkers of thiamine status.
What diseases are associated with abnormal thiamine diphosphate metabolism?
Altered ThDP metabolism is associated with gestational diabetes, diabetes mellitus, mitochondrial encephalomyopathy, and genetic disorders of thiamine transport such as thiamine-responsive megaloblastic anemia and biotin-thiamine-responsive basal ganglia disease.
Can thiamine supplementation increase thiamine diphosphate levels?
Yes, oral benfotiamine administration can raise erythrocyte ThDP concentrations in dialysis patients, and thiamine fortification increases plasma thiamine and erythrocyte ThDP in at-risk populations.
What is the role of transketolase in thiamine diphosphate metabolism?
Transketolase is a ThDP-dependent enzyme of the pentose phosphate pathway that catalyzes carbon transfer reactions, and its structure provides a model for ThDP binding and catalysis.
How can CRISPR be used to study thiamine diphosphate metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to test the causal roles of TPK1, SLC19A2, SLC19A3, SLC25A19, TKT, and other genes in ThDP metabolism.
What is the difference between thiamine and thiamine diphosphate?
Thiamine (vitamin B1) is the dietary precursor, while thiamine diphosphate is the phosphorylated, biologically active coenzyme form that participates in enzymatic reactions.
Where does thiamine diphosphate metabolism occur in the cell?
ThDP synthesis occurs mainly in the cytosol, while ThDP-dependent dehydrogenases function in the mitochondrial matrix; the mitochondrial carrier SLC25A19 connects these compartments.
Conclusion
GO:0042357, thiamine diphosphate metabolic process, is a central metabolic pathway that governs the synthesis, utilization, and turnover of the active coenzyme form of vitamin B1. Its importance spans energy metabolism, redox balance, and human disease, with strong evidence linking ThDP status to diabetes, gestational diabetes, and mitochondrial disorders. Advances in CRISPR-based models and biochemical assays continue to clarify the roles of TPK1, SLC19A2, SLC19A3, SLC25A19, TKT, and other genes in this process. For researchers, targeting GO:0042357 offers opportunities to dissect metabolic mechanisms and develop therapeutic strategies. EDITGENE's CRISPR services provide the tools needed to generate precise cell models and accelerate discoveries in thiamine diphosphate biology.
References
- 1. Bartáková V et al.. 2016. Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes.. Glycoconj J 33(4):591-8 PMID: 27287225
- 2. McCann A et al.. 2017. Comparable Performance Characteristics of Plasma Thiamine and Erythrocyte Thiamine Diphosphate in Response to Thiamine Fortification in Rural Cambodian Women.. Nutrients 9(7) PMID: 28661435
- 3. Hildenbrand JC et al.. 2023. Polyphosphate Kinases Phosphorylate Thiamine Phosphates.. Microb Physiol 33(1):1-11 PMID: 36041408
- 4. Ziegler D et al.. 2023. Association between diabetes and thiamine status - A systematic review and meta-analysis.. Metabolism 144:155565 PMID: 37094704
- 5. Frank T et al.. 2000. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.. Eur J Clin Pharmacol 56(3):251-7 PMID: 10952481
- 6. Tanaka J et al.. 1997. Treatment of mitochondrial encephalomyopathy with a combination of cytochrome C and vitamins B1 and B2.. Brain Dev 19(4):262-7 PMID: 9187476
- 7. Singleton CK et al.. 2001. Molecular mechanisms of thiamine utilization.. Curr Mol Med 1(2):197-207 PMID: 11899071
- 8. Kochetov GA et al.. 2014. Structure and functioning mechanism of transketolase.. Biochim Biophys Acta 1844(9):1608-18 PMID: 24929114
